Ambry delivers high-quality, accessible genetic testing for hereditary cancer and exome sequencing for rare disease. A trusted lab for 25 years.

Feb 3, 2025 · Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating ...

Discover why Ambry Genetics can help you provide more accurate results for your patients. Learn more today.

Feb 3, 2025 · Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating ...

Be empowered by understanding your risk for an inherited condition. Learn more from Ambry's patient site.

Feb 3, 2025 · Tempus Completes Acquisition of Ambry Genetics. Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it ...

Feb 3, 2025 · Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus.

Nov 11, 2024 · Tempus AI has announced its acquisition of Ambry Genetics, from KONICA MINOLTA, INC. for $600 million, comprising $375 million in cash and $225 million in shares. This strategic acquisition expands Tempus’ capabilities in hereditary cancer screening and genetic testing, adding to its precision medicine offerings.

Jan 15, 2025 · The Ambry CARE Program® helps providers identify high-risk patients, offers genetic testing and genetic counseling at scale, and gives patients insights to help them better manage their health. This blog looks at CARE from the patient’s perspective.

Feb 4, 2025 · Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating ...